Asia-Pacific Biosurgery Market Drivers Restraints and Opportunities 2021-2028

News provided by

Dec 13, 2021, 07:30 ET

DUBLIN, Dec. 13, 2021 /PRNewswire/ -- The "Asia-Pacific Biosurgery Market Drivers Restraints and Opportunities 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The Asia-Pacific biosurgery market is likely to witness growth at a CAGR of 7.56% through the years 2021-2028.

South Korea, Australia & New Zealand, India, ASEAN countries, Japan, China, and Rest of APAC form the market in this region.

In India, the rising burden of chronic diseases and the growing number of surgical procedures are key factors expected to augment the growth of the reviewed market during the estimated phase. For instance, in recent years, the number of patients suffering from cancer and cardiovascular diseases has increased.

Moreover, as per estimates, the country is likely to witness an endemic of osteoarthritis in the next few years. This will ultimately enhance the demand for biosurgery products, in turn, offering new opportunities to the biosurgery market in India in the upcoming years.

Furthermore, over the years, there has been substantial growth in knee replacement procedures for osteoarthritis within Australia. This increase is estimated to amplify the demand for biosurgery products.

Additionally, several new products are launched in the country, which will further support the growth of the studied market.

Besides, the rise in the geriatric population and the emergence of several lifestyle conditions have also enhanced the demand for biosurgery products. Hence, all these factors are responsible for positioning the Australian biosurgery market on a growth path.

Key Topics Covered:

Asia-Pacific Biosurgery Market - Summary

Industry Outlook

Impact of COVID-19 on Biosurgery Market
Trends in Biosurgery Technology
Key Insights
Porter's Five Forces Model
Threat of New Entrants
Threat of Substitute Products
Bargaining Power of Buyers
Bargaining Power of Suppliers
Competitive Rivalry
Market Attractiveness Index
Vendor Scorecard
Key Buying Outlook
Key Market Strategies
Contracts and Partnerships
Business Expansions, Announcements, & Divestitures
Acquisitions & Mergers
New Product Launches & Developments
Market Drivers
Growing Aging Population
Technological Advancements and Innovations in Healthcare Facilities
Surge in Surgical Treatments for Musculoskeletal Disorders
Prevalence of Spinal Fusion and Joint Reconstruction
Strong Focus on Research and Development
Market Challenges
High Cost of Surgeries
Complications Related to Immune Response
Usage of Minimally Invasive Surgeries
Market Opportunities
Research and Investments in Bioengineering
Development of Policies for Reimbursement and Compensation

Asia-Pacific Biosurgery Market - by Product

Asia-Pacific Biosurgery Market - by Application

Asia-Pacific Biosurgery Market - by Source Type

Asia-Pacific Biosurgery Market - Country Outlook

Competitive Landscape

Companies Mentioned

Baxter International Inc
Becton, Dickinson and Company
B Braun Melsungen AG
Csl Limited
Ethicon Inc (Johnson & Johnson)
Integra Lifesciences Holdings Corporation
Medtronic plc
Rti Surgical
Sanofi
Smith & Nephew plc
Stryker Corporation
Wright Medical Group Nv
Zimmer Biomet Holdings Inc

For more information about this report visit https://www.researchandmarkets.com/r/jux6su

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets